NAMPT and colorectal cancer: In this study, we first showed that FK866 significantly inhibited cell survival and reduced NAD levels in SW480 and LoVo cells, which suggests that the Nampt-mediated NAD biosynthetic mechanism is active in colorectal cancer cells.